NCT06779604 Dexmedetomidine and Dexamethasone Added as Adjuvant Infraclavicular Brachial Plexus Block in Upper Limb Surgery
| NCT ID | NCT06779604 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Umraniye Education and Research Hospital |
| Condition | Post Operative Pain |
| Study Type | OBSERVATIONAL |
| Enrollment | 44 participants |
| Start Date | 2026-02-01 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 44 participants in total. It began in 2026-02-01 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study was to investigate the effect of dexmedetomidine and dexamethasone added during USG-guided infraclavicular block on block onset time, total block time and time to first analgesic need in patients undergoing upper extremity surgery.
Eligibility Criteria
Inclusion Criteria: * 18-70 years * ASA I-II Exclusion Criteria: * Under 18 years of age and older than 70 years of age, * presence of brachial plexus injury, * patients with bleeding diathesis, * presence of allergy, -contralateral diaphragmatic paralysis, - * presence of nerve injury secondary to trauma, * pre-existing neuropathy of the surgical extremity, * presence of severe pulmonary, * renal and hepatic disease, * congestive heart failure (NYHA stage 3-4), * uncontrolled diabetes mellitus, * history of neuromuscular disease, * patients with extreme obesity or malnutrition (BMI \> 30 kg-1m2 or BMI \<20 kg-1m2), * presence of epilepsy, * history of peripheral vascular disease, * history of chronic pain or fibromyalgia, * pregnant and lactating patients, * patients with local infection at the injection site, * patients undergoing general anesthesia due to inadequacy of the block, * patients refusing to give informed consent, * history of recreational substance use, and chronic narcotic-based painkillers
Contact & Investigator
ZELİHA TUNCEL, ASC PROF
STUDY DIRECTOR
Umraniye ERH
Frequently Asked Questions
Who can join the NCT06779604 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Post Operative Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06779604 currently recruiting?
Yes, NCT06779604 is actively recruiting participants. Contact the research team at zelihalara@yahoo.com for enrollment information.
Where is the NCT06779604 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06779604 clinical trial?
NCT06779604 is sponsored by Umraniye Education and Research Hospital. The principal investigator is ZELİHA TUNCEL, ASC PROF at Umraniye ERH. The trial plans to enroll 44 participants.